| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $333.8M | +19.1% |
| R&D Expense | $72.4M | -11.6% |
| SG&A Expense | $123.8M | +5.0% |
| Operating Income | $40.8M | +120.0% |
| Pre-tax Income | $52.9M | +127.8% |
| Income Tax | $310K | +119.9% |
| Net Income | $52.5M | +127.6% |
| EPS (Basic) | $1.00 | +128.2% |
| EPS (Diluted) | $0.93 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $114.7M | +39.5% |
| Short-term Investments | $146.0M | -4.7% |
| Accounts Receivable | $64.6M | +26.5% |
| Inventory | $19.5M | +0.2% |
| Current Assets | $351.8M | +12.2% |
| Total Assets | $491.1M | +5.2% |
| Current Liabilities | $89.4M | +14.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $38.0M | +306.9% |
| Investing Cash Flow | -$483K | -101.2% |
| Financing Cash Flow | -$5.6M | +81.1% |
| +126.3% |
| Total Liabilities |
| $112.6M |
| -45.2% |
| Stockholders' Equity | $378.4M | +44.8% |